Carbapenem resistant Enterobacteriaceae - second update
Carbapenem resistance in Enterobacteriaceae such as Klebsiella pneumoniae and Escherichia coli poses a significant threat to patients and healthcare systems in all European Union/European Economic Area (EU/EEA) countries. Carbapenem-resistant Enterobacteriaceae (CRE) infections are associated with high mortality, primarily due to delays in administration of effective treatment and the limited availability of treatment options. Hypervirulent carbapenem-resistant K. pneumoniae strains have been reported presenting an additional threat with a potential for global dissemination. The spread of high risk clones and plasmids carrying carbapenemases in healthcare settings is a major cause of the spread of CRE in EU/EEA countries. Recent events of cross-border importation after patient transfer and large regional outbreaks as well as the worsening epidemiologic situation of carbapenemase-producing CRE in the EU/EEA highlight the high risk for further spread of CRE and the need for enhanced control efforts. Options for control are outlined in the respective section below.
Rapid risk assessment: Dengue outbreak in Réunion, France, and associated risk of autochthonous outbreak in the EU/EEA
This update of the risk assessment ‘Dengue outbreak in Réunion, France’ published on 5 July 2018, has been triggered by the significant size of the outbreak and its expected duration, which is anticipated to overlap with high vector activity in the southern EU.
Multi-country outbreak of Listeria monocytogenes clonal complex 8 infections linked to consumption of cold-smoked fish products
This joint ECDC-EFSA rapid outbreak assessment provides an assessment of the cross-border public health risk related to L. monocytogenes infections linked to the consumption of cold-smoked fish products, possibly originating from a single food processing company.
Risk assessment: Who is at risk of measles in the EU/EEA?
A large epidemic of measles has affected the EU/EEA Member States in the past three years, with 44 074 cases reported to ECDC by 30 Member States between 1 January 2016 and 31 March 2019.
Rapid outbreak assessment: Multi-country outbreak of Salmonella Poona infections linked to consumption of infant formula
This document provides an assessment of the cross-border public health risk related to the outbreak of Salmonella Poona infections in infants and young children linked to consumption of infant formula.
Rapid risk assessment: Multidrug-resistant Staphylococcus epidermidis
This rapid risk assessment addresses the public health risk associated with a previously unrecognised international spread of near pandrug-resistant strains of S. epidermidis as a cause of infection in several countries including EU Member States.
Multi-country outbreak of Listeria monocytogenes sequence type 8 infections linked to consumption of salmon products
A multi-country outbreak of 12 listeriosis cases caused by Listeria monocytogenes sequence type (ST) 8 has been identified through whole genome sequencing (WGS) analysis in three EU/EEA countries: Denmark (6 cases), Germany (5) and France (1).
Rapid risk assessment: Multi-country outbreak of Listeria monocytogenes serogroup IVb, multi-locus sequence type 6, infections linked to frozen corn and possibly to other frozen vegetables – first update
This document provides an updated assessment of the cross-border public health risk associated with consumption of frozen corn and possibly linked to other frozen vegetables contaminated with L. monocytogenes.
Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae - first update
This update of the 2016 ECDC Rapid Risk Assessment on carbapenem-resistant Enterobacteriaceae (CRE) evaluates the risk for patients and healthcare systems in EU/EEA countries due to the global spread of CRE.
Rapid risk assessment: Mass gathering event, FIFA World Cup, Russia 2018
The aim of this document is to assess the health risks related to communicable diseases for EU/EEA citizens during their stay in Russia for the 2018 FIFA World Cup, and the public health implications for European countries after travellers return to their countries.